SSA Swiss Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
SSA Swiss Advisors's PFE Position: Q2 2026 in Review
SSA Swiss Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 126,369 shares — an estimated $3.52M sold.
SSA Swiss Advisors first reported a position in PFE in Q1 2025 and held it in 5 quarters. The position peaked at $3.52M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- SSA Swiss Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- SSA Swiss Advisors sold 126,369 Pfizer shares in Q2 2026, an estimated $3.52M.
- SSA Swiss Advisors first reported a position in Pfizer in Q1 2025 and held it in 5 quarters.
- SSA Swiss Advisors's Pfizer position peaked at $3.52M in Q1 2026.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on SSA Swiss Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.